Pfizer-BioNTech vaccine appears effective against mutation in new coronavirus variants, study suggests

World 8-1-2021 CBC World 19
Covid Vaccinations, Toronto

Pfizer Inc. and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the U.S. drugmaker.

Read The Rest at CBC World- (opens a new tab)